 |
185 Diseases |  |
81 Trials |
|
81 Trials |  |
6476 News |  |
| «12...70717273747576777879808182 |
- levetiracetam / Generic mfg.
Trial termination: Efficacy of Keppra for Neonatal Seizures (clinicaltrials.gov) - Apr 16, 2013
P=N/A, N=2, Terminated, Sponsor: Stephanie Merhar, MD
Active, not recruiting --> Terminated; difficulty with recruitment
- levetiracetam / Generic mfg.
Enrollment change: Efficacy of Keppra for Neonatal Seizures (clinicaltrials.gov) - Apr 16, 2013
P=N/A, N=2, Terminated, Sponsor: Stephanie Merhar, MD
Active, not recruiting --> Terminated; difficulty with recruitment N=25 --> 2
- levetiracetam / Generic mfg.
Enrollment change: Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males (clinicaltrials.gov) - Mar 26, 2013
P1, N=32, Completed, Sponsor: UCB Japan Co. Ltd.
N=25 --> 2 N=50 --> 32
- | levetiracetam / Generic mfg.
Trial completion: Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males (clinicaltrials.gov) - Mar 26, 2013
P1, N=32, Completed, Sponsor: UCB Japan Co. Ltd.
N=50 --> 32 Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Trial initiation date: NEOLEV2: Efficacy of Intravenous Levetiracetam in Neonatal Seizures (clinicaltrials.gov) - Mar 24, 2013
P1/2, N=100, Recruiting, Sponsor: Richard H. Haas
Active, not recruiting --> Completed Initiation date: Dec 2012 --> Mar 2013
- levetiracetam / Generic mfg.
Enrollment open: NEOLEV2: Efficacy of Intravenous Levetiracetam in Neonatal Seizures (clinicaltrials.gov) - Mar 24, 2013
P1/2, N=100, Recruiting, Sponsor: Richard H. Haas
Initiation date: Dec 2012 --> Mar 2013 Not yet recruiting --> Recruiting
- levetiracetam / Generic mfg.
New P1 trial: SPAR: Seizure Prophylaxis in Aneurysm Repair (clinicaltrials.gov) - Feb 26, 2013
P1, N=400, Recruiting, Sponsor: University of Michigan Health System
- cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Enrollment open: Busulfan and Cyclophosphamide Followed By ALLO BMT (clinicaltrials.gov) - Feb 11, 2013
P=N/A, N=30, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| levetiracetam / Generic mfg.
Enrollment change: UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra (clinicaltrials.gov) - Jan 13, 2013
P4, N=516, Active, not recruiting, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting N=700 --> 516
- | levetiracetam / Generic mfg.
Enrollment closed, Monotherapy: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy (clinicaltrials.gov) - Jan 6, 2013
P3, N=71, Active, not recruiting, Sponsor: UCB Japan Co. Ltd.
N=700 --> 516 Recruiting --> Active, not recruiting
- | levetiracetam / Generic mfg.
Trial completion: Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients (clinicaltrials.gov) - Nov 26, 2012
P4, N=30, Completed, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | levetiracetam / Generic mfg.
New P1 trial: Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males (clinicaltrials.gov) - Nov 8, 2012
P1, N=32, Completed, Sponsor: UCB Japan Co. Ltd.
- | levetiracetam / Generic mfg.
New P1/2 trial: NEOLEV2: Efficacy of Intravenous Levetiracetam in Neonatal Seizures (clinicaltrials.gov) - Oct 31, 2012
P1/2, N=100, Recruiting, Sponsor: Richard H. Haas
- lorazepam / Generic mfg., levetiracetam / Generic mfg.
Trial withdrawal: STILL: Seizure Therapy With Intravenous Levetiracetam and Lorazepam (clinicaltrials.gov) - Oct 29, 2012
P2/3, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Terminated --> Withdrawn
- levetiracetam / Generic mfg.
Enrollment change: Keppra: Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures (clinicaltrials.gov) - Oct 20, 2012
P1/2, N=18, Completed, Sponsor: Richard H. Haas
Terminated --> Withdrawn N=24 --> 18
- levetiracetam / Generic mfg.
Trial completion: Keppra: Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures (clinicaltrials.gov) - Oct 20, 2012
P1/2, N=18, Completed, Sponsor: Richard H. Haas
N=24 --> 18 Recruiting --> Completed
- levetiracetam / Generic mfg.
Trial completion: Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI) (clinicaltrials.gov) - Aug 29, 2012
P2, N=144, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed Recruiting --> Completed
- fludarabine IV / Generic mfg., busulfan / Generic mfg., levetiracetam / Generic mfg.
Enrollment open: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) (clinicaltrials.gov) - Aug 26, 2012
P=N/A, N=30, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting --> Completed Not yet recruiting --> Recruiting
- levetiracetam / Generic mfg.
New P1/2 trial: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (clinicaltrials.gov) - Aug 7, 2012
P1/2, N=7, Completed, Sponsor: Michigan State University
- | levetiracetam / Generic mfg.
Trial completion: An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese (clinicaltrials.gov) - Aug 1, 2012
P1, N=24, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed
- | levetiracetam / Generic mfg.
Trial completion: A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers (clinicaltrials.gov) - Aug 1, 2012
P1, N=24, Completed, Sponsor: UCB, Inc.
Recruiting --> Completed Recruiting --> Completed
- ||| brivaracetam / Generic mfg.
New P3 trial, Adverse events: Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) (clinicaltrials.gov) - Jul 26, 2012
P3, N=29, Completed, Sponsor: UCB Pharma SA
- ||||||| pregabalin / Generic mfg., levetiracetam / Generic mfg.
Trial completion: Pregabalin Versus Levetiracetam In Partial Seizures (clinicaltrials.gov) - Jun 24, 2012
P3, N=509, Completed, Sponsor: Pfizer
Recruiting --> Completed Recruiting --> Completed
- | levetiracetam / Generic mfg.
New P1 trial: An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese (clinicaltrials.gov) - Jun 11, 2012
P1, N=24, Completed, Sponsor: UCB, Inc.
- | levetiracetam / Generic mfg.
New P1 trial: A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers (clinicaltrials.gov) - Jun 11, 2012
P1, N=24, Completed, Sponsor: UCB, Inc.
- | levetiracetam / Generic mfg.
Enrollment change: An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures (clinicaltrials.gov) - May 23, 2012
P2, N=16, Completed, Sponsor: UCB Japan Co. Ltd.
Recruiting --> Completed N=10 --> 16
- | levetiracetam / Generic mfg.
Trial completion: An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures (clinicaltrials.gov) - May 23, 2012
P2, N=16, Completed, Sponsor: UCB Japan Co. Ltd.
N=10 --> 16 Recruiting --> Completed
- levetiracetam / Generic mfg.
Enrollment change: Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases (clinicaltrials.gov) - May 16, 2012
P=N/A, N=0, Withdrawn, Sponsor: Northwestern University
Recruiting --> Completed N=30 --> 0
- | levetiracetam / Generic mfg.
Trial completion, Monotherapy: Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy (clinicaltrials.gov) - May 7, 2012
P3, N=409, Completed, Sponsor: Philipps University Marburg Medical Center
N=30 --> 0 Recruiting --> Completed
- levetiracetam / Generic mfg.
Trial completion: Effects of Levetiracetam (Keppra) on Alcohol Consumption (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=46, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Enrollment change: TRACK: Prevention of Post-traumatic Seizures With Levetiracetam (clinicaltrials.gov) - Feb 29, 2012
P3, N=23, Terminated, Sponsor: Rennes University Hospital
Active, not recruiting --> Completed N=600 --> 23
- levetiracetam / Generic mfg., carbamazepine / Generic mfg.
Trial completion: Photosensitivity Proof of Concept Trial (clinicaltrials.gov) - Feb 29, 2012
P2, N=6, Completed, Sponsor: The Epilepsy Study Consortium
N=600 --> 23 Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Enrollment change: IV Levetiracetam for the Treatment of Neonatal Seizures: a Pharmacokinetic and Preliminary Efficacy and Safety Study (clinicaltrials.gov) - Feb 1, 2012
P1/2, N=18, Completed, Sponsor: Richard H. Haas
Active, not recruiting --> Completed N=24 --> 18
- levetiracetam / Generic mfg.
Trial completion: IV Levetiracetam for the Treatment of Neonatal Seizures: a Pharmacokinetic and Preliminary Efficacy and Safety Study (clinicaltrials.gov) - Feb 1, 2012
P1/2, N=18, Completed, Sponsor: Richard H. Haas
N=24 --> 18 Recruiting --> Completed
- levetiracetam / Generic mfg.
New P1 trial: Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (clinicaltrials.gov) - Jan 26, 2012
P1, N=144, Recruiting, Sponsor: Children's Hospital Medical Center, Cincinnati
- || levetiracetam / Generic mfg.
New P3 trial, Monotherapy: An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy (clinicaltrials.gov) - Jan 8, 2012
P3, N=71, Active, not recruiting, Sponsor: UCB Japan Co. Ltd.
- | levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
New P4 trial, Monotherapy: Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (clinicaltrials.gov) - Dec 21, 2011
P4, N=353, Active, not recruiting, Sponsor: UCB Korea Co. Ltd.
- | levetiracetam / Generic mfg.
New P4 trial: Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients (clinicaltrials.gov) - Dec 11, 2011
P4, N=30, Completed, Sponsor: UCB, Inc.
- levetiracetam / Generic mfg.
Enrollment change: Levetiracetam for the Treatment of Alcohol Dependence and Anxiety (clinicaltrials.gov) - Dec 8, 2011
P2, N=3, Completed, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed N=30 --> 3
- |||||||||| lacosamide / Generic mfg.
New P3 trial: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Dec 1, 2011
P3, N=120, Completed, Sponsor: UCB, Inc.
- |||| lamotrigine liquid oral suspension / OWP Pharma
Trial completion: STEP-ONE: Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs (clinicaltrials.gov) - Dec 1, 2011
P4, N=361, Completed, Sponsor: Johannes Gutenberg University Mainz
N=30 --> 3 Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Trial completion: Dosing of Levetiracetam (Keppra) in Neonates (clinicaltrials.gov) - Nov 16, 2011
P1/2, N=7, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Active, not recruiting --> Completed Recruiting --> Completed
- New P2 trial, Post-transplantation: T-Cell Depleted Double UCB for Refractory AML (clinicaltrials.gov) - Nov 1, 2011
P2, N=24, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
- | levetiracetam / Generic mfg.
New P2 trial: Levetiracetam to Prevent Post-Traumatic Epilepsy (clinicaltrials.gov) - Oct 11, 2011
P2, N=126, Completed, Sponsor: Children's Research Institute
- | levetiracetam / Generic mfg.
Trial completion: Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects (clinicaltrials.gov) - Oct 4, 2011
P1, N=25, Completed, Sponsor: UCB, Inc.
Recruiting --> Completed Recruiting --> Completed
- | levetiracetam / Generic mfg., clonidine / Generic mfg.
Enrollment change: Comparison of Keppra and Clonidine in the Treatment of Tics (clinicaltrials.gov) - Sep 5, 2011
P4, N=12, Completed, Sponsor: Harvey S. Singer
Recruiting --> Completed N=20 --> 12
- | levetiracetam / Generic mfg., clonidine / Generic mfg.
Trial completion: Comparison of Keppra and Clonidine in the Treatment of Tics (clinicaltrials.gov) - Sep 5, 2011
P4, N=12, Completed, Sponsor: Harvey S. Singer
N=20 --> 12 Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Enrollment change: A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=31, Completed, Sponsor: Thomas Jefferson University
Active, not recruiting --> Completed N=45 --> 31